Prevention of the Development and Progression of Renal Disease
Open Access
- 1 July 2003
- journal article
- conference paper
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (suppl_2), S144-S147
- https://doi.org/10.1097/01.asn.0000070150.60928.06
Abstract
Prevention of the major causes of ESRD, hypertension, and diabetes, is possible. Careful glycemic control can prevent diabetes nephropathy. BP control can likely prevent the large majority of hypertensive renal disease. Testing for diabetic renal disease is well founded. In contrast, screening for hypertensive kidney disease is less well defined. Most established renal disease can be treated with glycemic control in the case of diabetes, BP treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and dietary protein restriction. Other therapeutic targets have been proposed, but are not well established. Future research should focus on defining the high risk patients, developing better markers of risk, and designing additional therapies. E-mail: HostetterT@extra.niddk.nih.govThis publication has 7 references indexed in Scilit:
- Effectiveness of Aldosterone Blockade in Patients With Diabetic NephropathyHypertension, 2003
- Slowing the progression of chronic renal failure: Economic benefits and patients' perspectivesAmerican Journal of Kidney Diseases, 2002
- Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 2001
- The Kidney in Cardiovascular DiseaseAnnals of Internal Medicine, 2001
- The Cost-Effectiveness of Treating All Patients with Type 2 Diabetes with Angiotensin-Converting Enzyme InhibitorsAnnals of Internal Medicine, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993